Solana Co — Director's Dealing 2018

May 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC (HSDT)
CIK: 0001610853
Period of Report: 2018-05-15

Reporting Person: GRIFFIN THOMAS E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-15	Stock Option (Right to Buy)	$10.99	A	15000	Acquired	2028-05-15	Class A Common Stock (15000)	Direct

Footnotes

F1: Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.

F2: Grant to the Reporting Person of a stock option under the Issuer's 2016 Stock Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.